Literature DB >> 409145

Radiographic manifestations of bone metastases from renal carcinoma.

G S Forbes, R A McLeod, R R Hattery.   

Abstract

From 1964 to 1974, 1,668 patients with renal carcinoma were seen at the Mayo Clinic. Bone metastases were present in 167 of these patients (only lung metastatic involvement ranked higher in frequency). More than one-third of the patients with bone metastasis from renal carcinoma had this as a presenting lesion of occult renal tumor. This group constituted 4% of all patients with renal carcinoma evaluated during the study period. While most bone lesions were in the pelvis and lower lumbar spine, any bone may be involved. All patients with bone metastases from renal carcinoma have a poor prognosis. However, some bone lesions appeared as long as 10 or more years after the initial tumor. The most common radiographic features are a lytic destructive process with indistinct margins, erosion of the cortex, and frequent expansion into the soft tissues. Pathological features are common in the long bones, and calcifications are occasionally seen. The synovial joints are not affected. A well defined sclerotic margin is a common finding after radiation treatment, although it is not a reliable indicator of the stability of the lesion.

Entities:  

Mesh:

Year:  1977        PMID: 409145     DOI: 10.2214/ajr.129.1.61

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

1.  Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis.

Authors:  Yusuke Tsuda; Tohru Nakagawa; Yusuke Shinoda; Atsushi Kanatani; Taketo Kawai; Satoru Taguchi; Yukio Yamada; Ryoko Sawada; Haruki Kume; Yukio Homma; Sakae Tanaka; Hirotaka Kawano
Journal:  Int J Clin Oncol       Date:  2017-01-02       Impact factor: 3.402

2.  Case report 191. Destructive (lytic) phase of Paget disease ("osteoporosis circumscripta") of calvaria.

Authors:  S V Kattapuram; N A Gadziala; S E Kirkham
Journal:  Skeletal Radiol       Date:  1982       Impact factor: 2.199

3.  Calvarial metastasis of a renal cell carcinoma, mimicking a primary alveolar soft part sarcoma, in a young girl-a rare case report.

Authors:  Bharat Rekhi; Rajiv Kumar; Santosh Menon; Seema Medhi; Sangeeta B Desai
Journal:  Pathol Oncol Res       Date:  2008-08-29       Impact factor: 3.201

4.  Sclerotic osseous metastases from renal cell carcinoma.

Authors:  Darryl B Sneag; Katherine M Krajewski; Stephanie Howard; Jyothi P Jagannathan; Kremena V Star; Nikhil Ramaiya
Journal:  Skeletal Radiol       Date:  2012-05-11       Impact factor: 2.199

5.  Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey.

Authors:  Daniele Santini; Giuseppe Procopio; Camillo Porta; Toni Ibrahim; Sandro Barni; Calogero Mazzara; Andrea Fontana; Alfredo Berruti; Rossana Berardi; Bruno Vincenzi; Cinzia Ortega; Davide Ottaviani; Giacomo Carteni; Gaetano Lanzetta; Vladimir Virzì; Matteo Santoni; Nicola Silvestris; Maria Antonietta Satolli; Elena Collovà; Antonio Russo; Giuseppe Badalamenti; Stefano Luzi Fedeli; Francesca Maria Tanca; Vincenzo Adamo; Evaristo Maiello; Roberto Sabbatini; Alessandra Felici; Saverio Cinieri; Giuseppe Tonini; Sergio Bracarda
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

6.  Radiographic characteristics of bone metastases from hepatocellular carcinoma.

Authors:  Hai-Yan Chen; Xiu-Mei Ma; Yong-Rui Bai
Journal:  Contemp Oncol (Pozn)       Date:  2012-11-20

7.  Osteoblastic bone metastases from renal cell carcinoma.

Authors:  Vladka Salapura; Irena Zupan; Bostjan Seruga; Gorana Gasljevic; Pavel Kavcic
Journal:  Radiol Oncol       Date:  2014-07-10       Impact factor: 2.991

8.  Skull metastasis revealing a renal tumor: A case report and review of the literature.

Authors:  Mohamed Badri; Ghassen Gader; Kamel Bahri; Ihsen Zammel
Journal:  Int J Surg Case Rep       Date:  2018-02-10

9.  Does Bone-targeted Therapy Benefit Patients with Metastatic Renal Cell Carcinoma?

Authors:  Emily C L Wong; Anil Kapoor
Journal:  Transl Oncol       Date:  2019-12-21       Impact factor: 4.243

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.